The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model
1992

Effects of Drugs on Colonic Cancer in Rats

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): A.E. Davis, F. Patterson, R. Crouch

Primary Institution: The Prince of Wales Hospital

Hypothesis

Do therapeutic drugs used for inflammatory bowel disease influence the development of colonic cancer?

Conclusion

Certain therapeutic drugs may act as co-carcinogens, increasing the incidence and size of colonic tumors in rats.

Supporting Evidence

  • Metronidazole, sulphasalazine, and low-dose 5-ASA increased tumor numbers.
  • High-dose 5-ASA reduced tumor size.
  • Olsalazine had no significant effect on tumor growth.

Takeaway

Some medicines for gut problems might actually help cancer grow in rats, while others can make it smaller.

Methodology

Inbred male Wistar rats were treated with various drugs and a carcinogen, and the development of colonic cancer was assessed after 20 weeks.

Limitations

The study was conducted in an animal model, which may not fully represent human responses.

Participant Demographics

Inbred male Wistar rats, weighing 160-280 grams.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication